BridgeMD
New treatment option for Central Obesity
Official title Effect of Ultrasound Cavitation on Insulin Resistance in Patients with Central Obesity in Female
ClinicalTrials.gov ID: NCT06729203
What this study is testing
- What it's testing
- The purpose of this study was to investigate the effect of ultrasound cavitation on insulin resistance, HbA1c and skin fold in patients with abdominal central obesity.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 40, women only
You may be able to join if
- Female people with central obesity.
- Female participants aged between 25 to 40 years.
- Body Mass Index (BMI) ranged from 30 to 35 kg/m2 as high BMI indicates more obesity and central obesity.
- Waist circumference greater than 88 cm, indicative of abdominal obesity.
- Diagnosed with insulin resistance (HOMA-IR \> 2.9).
You likely can't join if
- people diagnosed with DM (HbA1c more than 6.5%).
- History of metabolic disorders such as type 1 diabetes or thyroid disorders.
- people with BMI less than 30 kg/m2.
- people diagnosed with heart disease, liver as well as kidney diseases.
- people who take oral contraceptives.
- people with gestational Diabetes.
See the full eligibility criteria
- Female people with central obesity.
- Female participants aged between 25 to 40 years.
- Body Mass Index (BMI) ranged from 30 to 35 kg/m2 as high BMI indicates more obesity and central obesity.
- Waist circumference greater than 88 cm, indicative of abdominal obesity.
- Diagnosed with insulin resistance (HOMA-IR \> 2.9).
- Sedentary lifestyle, defined as engaging in less than 150 minutes of moderate-intensity physical activity per week.
- Willingness to provide informed consent and comply with study procedures.
- people diagnosed with DM (HbA1c more than 6.5%).
- History of metabolic disorders such as type 1 diabetes or thyroid disorders.
- people with BMI less than 30 kg/m2.
- people diagnosed with heart disease, liver as well as kidney diseases.
- people who take oral contraceptives.
- people with gestational Diabetes.
- Pregnant or breastfeeding women were excluded from the study.
- Use of weight-loss medications or supplements within the past six months.
- Previous surgical procedures for weight loss or body contouring.
- Contraindications to ultrasound therapy (e.g., metal implants in the abdomen, active skin infections).
- Participation in another clinical trial within the last three months.
The study team makes the final eligibility decision.
Where it's taking place
- Giza, Giza Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 25 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Giza, Giza Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.